The Association Between Use of Inhaled Corticosteroids and Long‐Acting Beta2‐Agonists During Pregnancy and Adverse Fetal Outcomes
ICS or LABA use during pregnancy was not associated with the risk of adverse fetal outcomes. Pregnant women with asthma should be advised to maintain controller therapy and avoid potential allergens to reduce the need for high-dose ICS.
Authors
- I‐Te Wang
- Yea‐Chwen Wu (ORCID: https://orcid.org/0000-0001-8352-8254)
- Chung‐Hsuen Wu (ORCID: https://orcid.org/0000-0003-0495-1922)
- Hsin‐Yi Huang (ORCID: https://orcid.org/0000-0002-4432-1864)
Institutions
- Harvard University (US)
- National Yang Ming Chiao Tung University (TW)
- Taipei Medical University Hospital (TW)
- Harvard Pilgrim Health Care (US)
- National Taiwan University Hospital (TW)
- Taipei Medical University (TW)
Publication Details
- Journal
- Respirology
- Published
- 2025-09-09
- DOI
- https://doi.org/10.1111/resp.70124
- Citations
- 2
- Primary Topic
- Pregnancy and Medication Impact
- Type
- article
- Field-Weighted Citation Impact
- 3.76
Funders
- Ministry of Science and Technology, Taiwan